HUBBELL INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data HUBBELL INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,505	3,669	4,482	3,947	3,683	4,194	4,948	5,373	5,629	5,845
Cost of revenue	2,400	2,514	3,181	2,775	2,597	3,043	3,476	3,496	3,723	3,781
Gross profit	1,105	1,155	1,300	1,172	1,086	1,152	1,472	1,877	1,906	2,064
Selling, general and administrative	615	636	744	645	591	619	763	850	813	855
Operating income	490	519	557	527	495	532	709	1,027	1,093	1,209
Interest expense	43.4	44.9	72.4	69.4	60.3
Other non-operating income	-16.5	-21.6	-17.6	-12.1	-2.3	5.4	4.5	-18.5	-7.2	-25.2
Pre-tax income	430	443	467	469	425	459	657	972	1,007	1,119
Income tax	133	193	101	101	89.8	88.2	140	215	222	227
Income from continuing operations				362	330	365	511	760	778
Net income to minority interests	4.8	6.8	5.9	6.5	4.8	6.1	5.5	6.2	5.7	4.8
Net income	293	243	360	401	351	400	546	751	779	887
EBITDA	581	617	705	665	639	681	858	1,177	1,305	1,415
EPS, basic	5.26	4.42	6.57	7.35	6.46	7.33	10.13	13.98	14.49	16.63
EPS, diluted	5.24	4.39	6.54	7.31	6.43	7.28	10.07	13.89	14.39	16.54
Shares, basic (weighted)	55.5	54.8	54.6	54.4	54.2	54.3	53.7	53.6	53.7	53.2
Shares, diluted (weighted)	55.7	55.1	54.9	54.7	54.5	54.7	54.1	54	54	53.5
Dividend per share	2.59	2.87	3.15	3.43	3.71	3.99	4.27	4.58	4.98	5.38

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	438	375	189	182	259	286	441	336	329	483
Short-term investments	11.2	14.5	9.2	14.2	9.3	9.4	14.3	12.6	15.9	15.4
Receivables	530	540	725	683	553	675	742	785	756	857
Inventory	532	635	651	633	527	662	741	833	1,010	1,084
Other current assets	40.1	39.6	69.1	62	71.8	66.8	84.3	130	147	155
Total current assets	1,551	1,604	1,644	1,574	1,588	1,879	2,021	2,167	2,258	2,594
Property, plant and equipment	440	458	502	505	439	460	528	653	727	841
Lease right-of-use assets				96.8	99.1	81.3	108	147	146	156
Goodwill	991	1,089	1,784	1,762	1,873	1,871	1,971	2,533	2,501	3,061
Intangible assets	432	460	820	782	771	682	670	1,196	1,080	1,394
Long-term investments	56.4	57.7	56.3	55.7	71.1	69.1	65.9	75.8	84.9	98.4
Other non-current assets	55	51.1	66.1	175	160	144	147	197	198	240
Total assets	3,525	3,721	4,872	4,903	5,085	5,282	5,403	7,081	6,848	8,229
Accounts payable	292	327	394	348	339	533	530	564	542	571
Accrued liabilities	156	175	227	262	225	263	334	365	372	451
Deferred revenue	11.8	10.2	27.7	31			45.8	112	135	161
Short-term debt	3.2	68.1	56.1	65.4	153	9.7	4.7	117	125	289
Total current liabilities	590	706	839	845	948	1,065	1,089	1,323	1,274	1,509
Long-term debt	991	987	1,737	1,506	1,437	1,436	1,438	2,023	1,443	2,036
Lease liabilities				71.7	71.9	58.3	84.9	119	117	121
Other non-current liabilities	68.2	118	117	115	597	521	506	661	720	826
Total liabilities	1,922	2,073	3,073	2,943	3,000	3,041	3,032	4,025	3,437	4,371
Total debt	991	987	1,762	1,540	1,437	1,436	1,438	2,038	1,443	2,036
Paid-in capital	15.4	11	1.3	0	4.9	0	0	6.1	2.6	6.4
Retained earnings	1,879	1,892	2,064	2,279	2,394	2,560	2,706	3,183	3,780	4,156
Other comprehensive income	-303	-270	-286	-333	-329	-331	-345	-312	-387	-315
Shareholders' equity	1,593	1,634	1,781	1,947	2,070	2,230	2,361	2,877	3,396	3,848
Minority interests	10.4	13.7	18.3	13.4	15.4	10.9	9.7	12.3	14.4	10
Total equity	1,603	1,648	1,799	1,961	2,085	2,241	2,371	2,889	3,411	3,858
Total liabilities and equity	3,525	3,721	4,872	4,903	5,085	5,282	5,403	6,914	6,848	8,229
Shares outstanding	55.5	54.9	54.7	54.5	54.4	54.5	53.7	53.7	53.8	53.3

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	298	250	366	407	356	406	551	758	785	892
Depreciation and amortization	90.9	98.2	148	138	145	149	149	150	212	206
Stock-based compensation	22.3	22.3	24.2	14.5	21.9	17.5	24.5	26.5	30.6	33
Deferred income tax	12.7	-14.3	49	4	1.4	9.2	-27.8	-18.9	2	11
Change in receivables	-42.3	3.9	-75.4	35.4	41.7	-125	-66.8	-1.6	22.2	-68.2
Change in inventory	18.4	-90.3	34.2	-6.3	45.8	-139	-66.5	-31	-24.2	-32.3
Change in payables	13.8	57.4	21.5	-29.3	20.7	195	-15.3	13.2	-13.6	6.3
Cash from operations	411	379	517	592	648	514	636	881	991	1,030
Capital expenditures	-67.2	-79.7	-96.2	-86.7	-82.8	-90.2	-129	-166	-180	-155
Acquisitions	-173	-184	-1,118	-70.8	-240	0.1	-177	-1,212	5.9	-958
Purchases of investments	-20	-20.9	-16.6	-14.2	-35.1	-11.4	-33.7	-25.4	-21	-25.2
Cash from investing	-230	-246	-1,201	-129	-329	-72.1	18.1	-1,380	-59.1	-1,095
Debt issued	397	298	948	0	225	299	0	600	0	1,000
Debt repaid	0	-300	-169	-225	-331	-300	0	0	-600
Stock issued	0
Share buybacks	-247	-92.5	-40	-35	-41.3	-11.2	-182	-30	-40	-225
Dividends paid	-144	-158	-172	-187	-201
Cash from financing	-59.4	-214	507	-471	-244	-433	-437	389	-923	204
Exchange rate effect	-27.3	18.3	-8.2	1.3	2.6	-3	-8.8	6.9	-16.4	13.9
Net change in cash	94.1	-62.6	-186	-7	77.6	30	154	-104	-7.7	153
Free cash flow	344	299	421	505	565	424	507	715	811	875
Income taxes paid	117	131	106	91.9	96.2	84	168	215	225	214

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $466.62 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	35.5%	Gross profit / revenue.
Operating margin	20.7%	Operating income / revenue.
EBITDA margin	24.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	19.1%	Pre-tax income / revenue.
Net margin	15.1%	Net income / revenue.
FCF margin	15.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	18.0%	Cash from operations / revenue.
Effective tax rate	20.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	24.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	10.8%	Net income / average total assets.
Return on invested capital (ROIC)	18.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	14.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.8%	Capital expenditures / revenue.
D&A / revenue	3.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	9.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	8.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	11.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	13.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	10.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	19.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	19.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	8.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	18.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	17.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	13.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	17.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	20.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	14.9%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	18.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	20.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	3.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	17.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	9.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	7.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	19.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	9.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	8.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	8.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	7.7%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	13.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	17.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	13.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	20.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	15.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.58x	Current assets / current liabilities.
Quick ratio	0.84x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.29x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.54x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	24.2%	Total debt / total assets.
Liabilities / assets	55.1%	Total liabilities / total assets.
Net debt	$1.52B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.04x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$1.03B	Current assets - current liabilities.
Goodwill and intangibles / assets	52.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$657.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.71x	Revenue / average total assets.
Fixed asset turnover	7.11x	Revenue / average property, plant and equipment.
Inventory turnover	3.40x	Cost of revenue / average inventory.
Days inventory	107 days	365 x average inventory / cost of revenue.
Receivables turnover	6.15x	Revenue / average receivables.
Days sales outstanding	59 days	365 x average receivables / revenue.
Days payables	57 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	110 days	Days inventory + days sales outstanding - days payables.
FCF conversion	100.4%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	15.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$16.93	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$112.50	Revenue / diluted weighted shares.
FCF per share	$17.06	Free cash flow / diluted weighted shares.
Operating cash flow per share	$20.24	Cash from operations / diluted weighted shares.
Book value per share	$70.71	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$12.33	Tangible book value / shares outstanding.
Cash per share	$9.70	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	29.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$24.65B	Share price x shares outstanding.
Enterprise value	$26.17B	Market cap + total debt - cash - short-term investments.
P/E	27.2x	Market cap / net income. Only when net income is positive.
P/S	4.11x	Market cap / revenue.
P/B	6.54x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	27.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	22.8x	Market cap / cash from operations, when positive.
EV/Sales	4.36x	Enterprise value / revenue.
EV/EBIT	21.1x	Enterprise value / operating income, when both are positive.
EV/EBITDA	17.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	28.8x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.7%	Free cash flow / market cap.
Earnings yield	3.7%	Net income / market cap (the inverse of P/E).
Shareholder yield	1.1%	(Dividends paid + share buybacks) / market cap.
PEG	1.51x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was HUBBELL INC's revenue in fiscal 2025?

HUBBELL INC reported revenue of $5.84B for fiscal 2025, 3.8% higher than the year before.

Was HUBBELL INC profitable in fiscal 2025?

Yes. Net income was $887.1M, a net margin of 15.2%.

How much free cash flow did HUBBELL INC generate in fiscal 2025?

Cash from operations of $1.03B minus capital expenditures of $155.1M left free cash flow of $874.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to HUBBELL INC